Abiopharma

🔍 Xu Tony (Executive)

Company: DoorDash, Inc. (DASH)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 16,667 shares of Class A Common Stock at $7.16 per share (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,167.00 | transaction_form_type: 4
• Sold 16,667 shares of Class A Common Stock at $230.002 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 8,159.00 | Footnotes: F3
• Sold 16,667 shares of Stock Option (right to buy) at $7.16 per share (Derivative)
  Date: 2026-09-01 | Code: M | Expires: 2028-10-09 | equity_swap_involved: 0 | shares_owned_after: 1,134,138.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan that was adopted on September 9, 2025.
• F2: This sale price represents the weighted average sale price of the shares sold ranging from $230.00 to $230.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F3: The shares are held by TXX Investments LLC, whose sole member is The Article 4 Trust under Library Trust.
• F4: The shares underlying the option are fully vested and immediately exercisable.